A fed-batch reaction is harder to design than a batch process because of the need to specify all the variables and quantities.

The company seeks to accelerate drug development by automating analysis of study samples.

ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of ...